Beijing LabTech Instruments (688056.SH) achieved a net profit of 39.71 million yuan in 2024, an increase of 44.08% year-on-year.

Beijing LabTech Instruments (688056.SH) released its 2024 annual performance report, with total operating revenue of 424 million yuan for the year, a year-on-year increase of 2.01%; net profit attributable to owners of the parent company was 39.7131 million yuan, a year-on-year increase of 44.08%; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 31.5286 million yuan, a year-on-year increase of 35.31%; basic earnings per share were 0.59 yuan. Due to the increase in raw material costs and the introduction of new production lines in the same period of the previous year, the overall product gross profit margin decreased slightly in the reporting period. In the current reporting period, there was no new production capacity input, and raw material costs remained stable, eliminating the factors influencing costs. The overall gross profit margin rebounded slightly for the year. At the same time, the company strengthened cost and expense management and improved employee efficiency, successfully maintaining stable control over expenses in the reporting period without any increase.